Sort
261,768 grants matching “gene therapy”
Development of a PO-administered beta-lactam-tarocin combination agent to treat methicillin susceptible and methicillin resistant Staphylococci
$974,575Terry Roemer · Prokaryotics, Inc. · R44 · FY2024 · AI
Metabolic Networks and Pathways in Alzheimer's Disease
$974,544Rima F Kaddurah-Daouk · Duke University · R01 · FY2014 · AG
Immune reconstitution following autologous and allogeneic stem cell transplant
$974,472Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Animal Models Of Neuropsychiatric Disorders
$974,415Jacqueline N. Crawley · National Institute Of Mental Health · ZIA · FY2012 · MH
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
$974,407Lydie Trautmann · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2023 · MH
Lead optimization of novel ML-IAP antagonists to treat lung cancer
$974,339Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA
Lead optimization of novel ML-IAP antagonists to treat lung cancer
$974,339Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA
ORAL MANIFESTATIONS OF AIDS
$974,317University Of California San Francisco · P01 · FY2001 · DE
Genomics of fungal pathogens: population diversity, outbreaks, and host response
$974,301Christina A Cuomo · Broad Institute, Inc. · U19 · FY2015 · AI
Interaction between nuclear epigenetic and metabolic pathways in cancer
$974,274Shelley L Berger · University Of Pennsylvania · R35 · FY2025 · CA
Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis
$974,241Kurt Kohn · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Genetic Determinants of Epilepsy in Murine Systems
$974,220Wayne N. Frankel · Columbia University Health Sciences · R01 · FY2021 · NS
Depletion, Repopulation and Tolerance in Non-Sensitied Recipients
$974,213Allan D. Kirk · Duke University · U19 · FY2020 · AI
Precision quality check of immunotherapeutics via single-cell cytokine mapping
$974,208Jing Zhou · Isoplexis, Inc. · R44 · FY2017 · CA
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$974,093James L Riley · University Of Pennsylvania · U19 · FY2022 · AI
Core A - Administrative Core
$974,087Gil Dan Rabinovici · University Of California, San Francisco · P30 · FY2024 · AG
Developmental Core
$974,063Bruce D. Rapkin · Sloan-Kettering Inst Can Research · U54 · FY2009 · CA
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
$974,060Lydie Trautmann · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2025 · MH
LncRNA mechanisms in cancer
$974,029Howard Y Chang · Stanford University · R35 · FY2017 · CA
LncRNA mechanisms in cancer
$974,029Howard Y Chang · Stanford University · R35 · FY2018 · CA
FSHD iPS cells: Modeling disease mechanisms, genetic correction and cell therapy
$974,014Michael Kyba · University Of Minnesota · RC2 · FY2010 · AR
A Phase I Study of Mistletoe Extract on PK, PD, and Safety of Gemcitabine in CA
$974,000Patrick J Mansky · Complementary & Integrative Health · Z01 · FY2007 · AT
Developing functional and authenticated RPE tissue from iPS cells
$973,986Kapil Bharti · National Eye Institute · ZIA · FY2020 · EY
HLA and KIR Genomics in Inflammatory Bowel Disease
$973,852Elizabeth A Trachtenberg · Children'S Hospital & Res Ctr At Oakland · U01 · FY2010 · AI
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis
$973,846Ronald A Bush · National Institute On Deafness And Other Communication Disorders · ZIA · FY2018 · DC